Facility will enable transformational research on the composition and structure of chemical samples SANTA CLARA, Calif. & BURLINGTON, Vt. — Agilent Technologies Inc. (NYSE: A) and the University of Vermont (UVM) today announced the establishment of the Agilent Laboratory for Chemical Analysis (ALCA). The facility will be a hub for advanced instrumentation that will allow students, institutional colleagues, […]

BOSTON — TetraScience, the R&D Data Cloud company, announced today a new collaboration with PerkinElmer’s Informatics business to facilitate faster and better scientific decision-making for customers of PerkinElmer’s Signals ResearchTM Suite, a leading cloud-based, electronic lab notebook and informatics platform. Around the world today, millions of scientists at leading and emerging scientific research organizations use PerkinElmer’s […]

Fully automated GeoMx RNA workflow reduces hands-on time, allowing users to prepare up to 30 slides in one day with high reproducibility SEATTLE — NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the release of a fully automated GeoMx® RNA protocol on BOND RX […]

Agreement to leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies CAMBRIDGE, Mass., & WALTHAM, Mass. —  Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced a 15-year strategic collaboration agreement […]

LIMERICK, PA Rockland Immunochemicals, Inc. (Rockland), a leading life science reagents manufacturer and service provider with years of expertise in antibodies, assay, and reagent development for early- to late-stage bioprocessing and the Jefferson Institute for Bioprocessing (JIB), a full-service development and training organization specializing in biologics and biopharmaceuticals announced today that an agreement has been signed […]

Element Biosciences and Agilent Technologies have integrated Element’s AVITI System with Agilent’s SureSelect target enrichment panels. Element Biosciences Inc., developer of a new and disruptive DNA sequencing platform, today announced a partnership with Agilent Technologies demonstrating the integration of Element’s AVITI System with Agilent Technologies’ industry-leading SureSelect target enrichment panels, providing customers greater access to these genomic […]

This partnership integrates the performance, cost, and flexibility of the Element AVITI System with New England Biolabs’ powerful NEBNext Ultra II library prep technology to provide a unique end-to-end solution for Element sequencing customers and further expand the well-established NEBNext Ultra II technology. Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, […]

Element Biosciences and QIAGEN partner to validate QIAGEN’s NGS library prep on Element’s AVITI System. Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a partnership with QIAGEN to validate its leading NGS library prep and target enrichment offerings on the AVITI System. This partnership demonstrates the compatibility of the Element AVITI […]

Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a key technical milestone using the Roche KAPA HyperPlus and KAPA EvoPlus library preparation and target enrichment kits in microbial whole genome, human whole genome, and human whole-exome sequencing applications. High-quality library preparation is critical for high-performance sequencing. Roche, through its KAPA brand, […]

Genomenon produces and delivers comprehensive database of actionable variants for rare genetic disease BPAN Genomenon®Inc., recently announced a partnership with Don’t Forget Morgan, a nonprofit support organization focused on rare disease patients living with Beta-Propeller Protein-Associated Neurodegeneration (BPAN), a progressive disease causing abnormal iron deposits in the brain leading to profound developmental delays. The goal of this […]